Table 1.
Characteristics | No biochemical recurrence (n = 86) | Biochemical recurrence (n = 47) | p | ||
---|---|---|---|---|---|
N° (%) | N° (%) | ||||
Age (year) | 0.25 | ||||
<65 | 52 (39.5) | 64.87 ± 6.47 | 28 (40.4) | 66.21 ± 6.27 | |
>65 | 34 (60.5) | 19 (59.6) | |||
Tumor stage | <0.0001 | ||||
T2 | 79 (91.9) | 27 (57.4) | |||
T3–4 | 7 (8.1) | 20 (42.6) | |||
Score gleason | <0.003 | ||||
2–4 | 14 (16.3) | 4 (8.5) | |||
5–6 | 50 (58.1) | 17 (36.2) | |||
7–10 | 22 (25.6) | 26 (55.3) | |||
PSA (ng/ml)a | 0.051 | ||||
<10 | 65 (75.6) | 28 (59.6) | |||
>10 | 21 (24.4) | 19 (40.4) |
Mean age (±SD) in each group (with recurrence and with no recurrence) is shown
aPSA level before patients were operated